Status:
COMPLETED
Delta Q Value to Discriminate Detrusor Underactivity From Bladder Outlet Obstruction
Lead Sponsor:
Ain Shams University
Conditions:
Urinary Obstruction
Detrusor Underactivity
Eligibility:
MALE
50+ years
Phase:
PHASE2
PHASE3
Brief Summary
To determine the significance of delta Q value (Qmax - Qave) in discrimination between BOO and DU, to avoid invasive studies (pressure flow studies (PFSs)) and replace them with noninvasive study (uro...
Detailed Description
lower urinary tract symptoms (LUTS) in old male patients are usually secondary to prostatic hyperplasia. However, it is becoming clear nowadays that prostatic enlargement is not always the cause of ma...
Eligibility Criteria
Inclusion
- male patients aged over 50 years complaining of voiding symptoms
- International Prostatic Symptom Score (IPSS) 8 points or more,
- serum prostate-specific antigen (PSA) below 4 ng/ml
- no hematuria or pyuria.
Exclusion
- Patients who were unable to complete the voiding study were deemed not eligible to participate in this review.
- patients with neurological causes of voiding dysfunction
- history of urinary tract abnormalities/lithiasis, lower urinary tract surgeries, urinary tract malignancy.
- acute UTI were excluded.
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2021
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT05359484
Start Date
January 1 2019
End Date
May 1 2021
Last Update
May 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ahmed Maher
Cairo, Cairo Governorate, Egypt, 11757